Argenx to buy Forte Biosciences for about $2.2 billion

https://www.wsj.com/tech/biotech/argenx-to-buy-forte-biosciences-for-2-2-billion-41653c87

Primarily driven by the IL-15 pathway drug trial for vitiligo.

Very positive news.